Eye-Scanning app could revolutionize addiction monitoring

NCT ID NCT06629740

Completed Knowledge-focused Sponsor: Kontigo Care AB Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests a CE-marked mobile app that scans a person's eyes to detect whether they have used certain drugs. Healthy volunteers will take a common medicine that mimics the effects of cannabis or amphetamines, then use the app to see if the eye measurements change. The goal is to improve the app's ability to monitor drug use in people being treated for substance use disorder.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a mobile phone application (Previct Drugs) that performs eye-scanning to measure pupil and eye parameters
What this could lead to: If successful, this could provide a non-invasive, remote way to monitor drug use in people undergoing treatment for substance use disorder.
What could go wrong: This is a small, early-stage study in healthy volunteers using simulated drug intake, so results may not translate directly to real-world patients or all substances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDER (SUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUBSTANCE USE DISORDER (SUD)

Contacts and locations

Show contact details

Locations

Leiden University Medical Center (LUMC)

Leiden, 2333 ZA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.